Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
Title:
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
Author:
Lipton, Jeffrey H Chuah, Charles Guerci-Bresler, Agnès Rosti, Gianantonio Simpson, David Assouline, Sarit Etienne, Gabriel Nicolini, Franck E le Coutre, Philipp Clark, Richard E Stenke, Leif Andorsky, David Oehler, Vivian Lustgarten, Stephanie Rivera, Victor M Clackson, Timothy Haluska, Frank G Baccarani, Michele Cortes, Jorge E Guilhot, François Hochhaus, Andreas Hughes, Timothy Kantarjian, Hagop M Shah, Neil P Talpaz, Moshe Deininger, Michael W